In the evolving fi DANEGAPTIDE - Inxight Drugs eld of biochemical research, few molecules have garnered as much interest as the danegaptide peptide composition. As someone who follows advancements in peptide science, I have found the structural precision of this molecule to be truly fascinating. Often referred to by its laboratory designation, GAP-134, or the internal code ZP1609, this compound represents a significant leap in our understanding of gap junction biology.
Understanding the Structural Integrity
The danegaptide peptide composition is defined by its precise molecular architecture. Chemically identified as (2S, 4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid, it is a dipeptide analogue that stands out for its structural simplicity and functional potency. Unlike larger, m Danegaptide (GAP-134)|Gap Junction Modulator ore complex protein chains, danegaptide is characterized by two alpha-amino acids joined by a peptide bond, a configuration that allows for high selectivity in its interaction with connexin proteins, particularly connexin 43 (Cx43).
Whe Gap junction intercellular communication modulators and n examining its data profile, researchers often reference the molecular formula C14H17N3O4. For those interested in the salt form, Danegaptide Hydrochloride (CAS Number: 943133-81-1) is frequently utilized in laboratory settings due to its stability and solubility profile. With a molecular weight of 327.76 for the hydrochloride form, it is a relatively small, efficient molecule.
The Role of Gap Junction Modulators
What makes this compound a frequent subject of study is its identity as a potent, selective and orally active gap junction modifier. Gap junctions are essential for intercellular communication, allowing cells to share ions and small molecules. In many experimental models, Danegaptide is a selective, orally active gap junction modifier that has shown promise in helping maintain cellular homeostasis.
From my perspective, the development of Danegaptide as a therapeutic peptide—originally pioneered by Zealand Pharma—highlights the importance of small-molecule design in mimicking natural regulatory processes. It functions by optimizing intercellular communication, effectively acting as a bridge in cellular signaling pathways.
Comparative In Zealand Pharma Presented Danegaptide As A Case Study sights and Research Context
In the broader landscape of peptide research, it is helpful to contrast danegaptide with other sequences. For instance, while some studies look at complex chains like the "Ac-DTyr-DPro- DHyp-Gly-DAIa-Gly-Nhb" sequences or the 16-amino acid mimetics, danegaptide remains distinct due to its dipeptide nature. Its synthesis, involving precursors such as 6, Enantiopure6,7-diacetoxy-3-t-butoxycarbonylamino-azabicyclo[3.3.0]octan-2-one-8-carboxylic acid 14(pyrrolizidinone amino acid) was synthesized in 14 steps and Read more 7-diacetoxy-3-t-butoxycarbonylamino-azabicyclo[3.3.0]octan-2-one-8-carboxylic acid 14, showcases the high level of synthetic chemistry required to produce such enantiopure compounds.
It is also worth noting the work being conducted by organizations like Breye Therapeutics, which has brought new visi Oct 15, 2025—Danegaptidenegated carboxyfluorescein dye uptake and ATP release and protected against protein changes associated with tubular injury. Blocking Read more bility to this molecule. Their research into the stability of the vasculature and its protective mechanisms underscores why danegaptide is considered a first-in-class candidate in various research arenas. Whether it is referred to as danegaptide or by its chemical name (2S, 4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid, the impact of this peptide on modern research is undeniable.
Reflections on Utility
For those of us reviewing the literature, the consistency of the results surrounding this compound is encouraging. Danegaptid The Antiarrhythmic Dipeptide ZP1609 (Danegaptide) When e es un modificador de unión de brecha potente, selectivo y oralmente activo, and its ability to maintain its efficacy across different experimental platforms speaks to its robust design.
As the scientific community continues to explor Feb 9, 2026—Danegaptideis described as a first‑in‑class oral small molecule designed to stabilise the vasculature and protect against retinal capillary Read more e the danegaptide peptide composition, we gain deeper insights into how small, targeted molecules can influence complex biological systems. It serves as a reminder that in the world of peptides, sometimes the most effective solutions are the most elegantly simple ones.
***
*Disclaimer: This article is for informational purposes based on publicly available research and personal review of scientific literature. It does not provide medical advice, diagnosis, or treatment recommendations.*